The result of the OVA-induced airway inflammation model shows that Th2 suppression in BALF evaluating IL-4 and IL-5 cytokine production both in preventive and therapeutic administration is possible by delivering an antigen to the cell surface by mRNA-LNP technology. This evidence concerns the gene IL4 and inflammation.